Incidence and prevalence of vitiligo by gender and age in the Colombian population

Paola Andrea Rueda , Sara Orozco , Juan Raúl Castro , Ángela María Londoño, Elsa María Vásquez, Andrea Arango, Carlos Esteban Builes , .

Keywords: vitiligo, epidemiology, prevalence, incidence, Colombia

Abstract

Introduction. Vitiligo is an acquired depigmenting skin disorder characterized by achromic macules resulting from the selective destruction of melanocytes. Epidemiological information regarding this condition remains limited in Colombia and Latin America, with prevalence varying across geographical regions.
Objective. To estimate the incidence and prevalence of vitiligo in Colombia by age, gender, and region.
Materials and methods. A retrospective study was conducted utilizing real-world clinical practice data retrieved from the national registry SISPRO (Sistema de Información para la Protección Social) spanning the period from 2015 to 2022.
Results. Over the eight-year follow-up period (2015-2022) in Colombia, 131,494 patients were diagnosed with vitiligo. In 2016, the lowest incidence was observed, with 26 cases per 100,000 inhabitants, whereas in 2019, the highest incidence was recorded at 47 cases per 100,000 inhabitants, representing a difference of 11,175 cases between the two years. Incidence decreased in 2020 to 28.15 cases per 100,000 inhabitants. Prevalence exhibited a linear increase over the years, with the highest rates observed in 2018 and 2019.
Conclusions. This study represents the first comprehensive report on epidemiological data concerning individuals with vitiligo in Colombia, and the second in South America. It contributes to the understanding of this condition, revealing an upward trend in incidence and prevalence. These findings also provide insights into primary treatment modalities, which are probably associated with improved case registration by healthcare providers.

Downloads

Download data is not yet available.

References

Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, et al. The prevalence of vitiligo: A metaanalysis. PLoS ONE. 216;11:e0163806. https://doi.org/10.1371/journal.pone.0163806

Mastacouris N, Strunk A, Garg A. Incidence and prevalence of diagnosed vitiligo according to race and ethnicity, age, and sex in the US. JAMA Dermatol. 2023;159:986. https://doi.org/10.1001/jamadermatol.2023.2162

Pandya AG. Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort. Acad Dermatol Venereol. 2023;37:2159-60. https://doi.org/10.1111/jdv.19502

Ezzedine K, Seneschal J, Da Silva A, Préaubert N, Lamblin A, Delattre C, et al. Vitiligo patient population and disease burden in France: VIOLIN study results from the CONSTANCES cohort. Acad Dermatol Venereol. 2023;37:2249-58. https://doi.org/10.1111/jdv.19447

Cesar Silva De Castro C, Miot HA. Prevalence of vitiligo in Brazil—A population survey. Pigment Cell Melanoma Res. 2018;31:448-50. https://doi.org/10.1111/pcmr.12681

Ray M, Gandhi K, Maughn K, Pandya AG. Diagnosed prevalence and incidence of vitiligo in the United States: Analysis of employer-sponsored insurance claims. JID Innov. 2023;3:100199. https://doi.org/10.1016/j.xjidi.2023.100199

Al Hammadi A, Silva De Castro CC, Parmar NV, Ubogui J, Hatatah N, Ahmed HM, et al. Prevalence and burden of vitiligo in Africa, the Middle East, and Latin America. Skin Health Dis. 2024;4:e317. https://doi.org/10.1002/ski2.317

Londoño-García A, Arango-Salgado A, Orozco-Covarrubias MD, Jansen AM, Rico-Restrepo M, Riviti MC, et al. The landscape of vitiligo in Latin America: A call to action. J Dermatolog Treat. 2023;34:2164171. https://doi.org/10.1080/09546634.2022.2164171

Chang WL, Lee WR, Kuo YC, Huang YH. Vitiligo: An autoimmune skin disease and its immunomodulatory therapeutic intervention. Front Cell Dev Biol. 2021;9:797026. https://doi.org/10.3389/fcell.2021.797026

Joge RR, Kathane PU, Joshi SH. Vitiligo: A narrative review article. Cureus. 2022;14:e29307. https://doi.org/10.7759/cureus.29307

Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, et al. Vitiligo is not a cosmetic disease. J Am Acad Dermatol. 2015;73:883-5. https://doi.org/10.1016/j.jaad.2015.07.039

Wong PM, Yang L, Yang L, Wu H, Li W, Ma X, et al. New insight into the role of exosomes in vitiligo. Autoimmun Rev. 2020;19:102664. https://doi.org/10.1016/j.autrev.2020.102664

How to Cite
1.
Rueda PA, Orozco S, Castro JR, Londoño Ángela M, Vásquez EM, Arango A, et al. Incidence and prevalence of vitiligo by gender and age in the Colombian population. Biomed. [Internet]. 2025 Sep. 22 [cited 2026 Jan. 12];45(4):566-73. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/7522

Some similar items:

Published
2025-09-22
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
Escanea para compartir
QR Code